Dorman Followwill Sorrento Therapeutics, Inc. (SRNE) insider trading activity

SRNE Quotes by TradingView

Dorman Followwill is Director of Sorrento Therapeutics, Inc.. Currently has a direct ownership of 2,130 shares of SRNE, which is worth approximately $702. The most recent transaction as insider was on Dec 16, 2020, when has been sold 1,000 shares (Common Stock) at a price of $7.13 per share, resulting in proceeds of $7,130. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.13K
0% 3M change
0% 12M change
Total Value Held $702

Dorman Followwill Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 16 2020
SELL
Open market or private sale
$7,130 $7.13 p/Share
1,000 Reduced 31.95%
2,130 Common Stock
Nov 11 2020
BUY
Acquisition or disposition by will or laws
-
1,000 Added 24.21%
3,130 Common Stock

Also insider at

VCKA
Vickers Vantage Corp. I Financial Services
DF

Dorman Followwill

Director
San Diego, CA

Track Institutional and Insider Activities on SRNE

Follow Sorrento Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRNE shares.

Notify only if

Insider Trading

Get notified when an Sorrento Therapeutics, Inc. insider buys or sells SRNE shares.

Notify only if

News

Receive news related to Sorrento Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SRNE